Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katja Simon-Keller

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Expert Opinion on Therapeutic Targets|December 13, 2012
Targeting the fetal acetylcholine receptor in rhabdomyosarcomaKatja Simon-Keller, Stefan Barth, Angela Vincent, et al.
ISRN Oncology|August 25, 2012
Variable Resistance of RMS to Interferon γ SignalingKatja Simon-Keller, Katharina Mößinger, Anna-Lena Bohlender, et al.
International Journal of Oncology|July 7, 2022
Tumor suppressive functions of WNT5A in rhabdomyosarcomaNada Ragab, Julia Bauer, Anja Uhmann, et al.
Experimental Neurology|December 29, 2015
Myf5 and Myogenin in the development of thymic myoid cells - Implications for a murine in vivo model of myasthenia gravisBo Hu, Katja Simon-Keller, Stefan Küffer, et al.
Seminars in Immunopathology|February 4, 2021
Thymus and autoimmunityAlexander Marx, Yosuke Yamada, Katja Simon-Keller, et al.
Scientific Reports|June 27, 2019
CD163+ immune cell infiltrates and presence of CD54+ microvessels are prognostic markers for patients with embryonal rhabdomyosarcomaJakob Nikolas Kather, Christian Hörner, Cleo-Aron Weis, et al.
Histopathology|October 30, 2016
Vascular architecture as a diagnostic marker for differentiation of World Health Organization thymoma subtypes and thymic carcinomaFrederick Pfister, Hussam Hussain, Djeda Belharazem, et al.
Oncotarget|December 15, 2016
LEF1 reduces tumor progression and induces myodifferentiation in a subset of rhabdomyosarcomaJulia Dräger, Katja Simon-Keller, Tobias Pukrop, et al.
Scientific Reports|September 28, 2016
Gene expression profiling reveals aryl hydrocarbon receptor as a possible target for photobiomodulation when using blue lightAnja Becker, Anna Klapczynski, Natalia Kuch, et al.
Frontiers in Pediatrics|December 21, 2018
Canonical WNT/β-Catenin Signaling Plays a Subordinate Role in RhabdomyosarcomasNada Ragab, Florian Viehweger, Julia Bauer, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Expert Opinion on Therapeutic Targets|December 13, 2012
Targeting the fetal acetylcholine receptor in rhabdomyosarcomaKatja Simon-Keller, Stefan Barth, Angela Vincent, et al.
ISRN Oncology|August 25, 2012
Variable Resistance of RMS to Interferon γ SignalingKatja Simon-Keller, Katharina Mößinger, Anna-Lena Bohlender, et al.
International Journal of Oncology|July 7, 2022
Tumor suppressive functions of WNT5A in rhabdomyosarcomaNada Ragab, Julia Bauer, Anja Uhmann, et al.
Experimental Neurology|December 29, 2015
Myf5 and Myogenin in the development of thymic myoid cells - Implications for a murine in vivo model of myasthenia gravisBo Hu, Katja Simon-Keller, Stefan Küffer, et al.
Seminars in Immunopathology|February 4, 2021
Thymus and autoimmunityAlexander Marx, Yosuke Yamada, Katja Simon-Keller, et al.
Scientific Reports|June 27, 2019
CD163+ immune cell infiltrates and presence of CD54+ microvessels are prognostic markers for patients with embryonal rhabdomyosarcomaJakob Nikolas Kather, Christian Hörner, Cleo-Aron Weis, et al.
Histopathology|October 30, 2016
Vascular architecture as a diagnostic marker for differentiation of World Health Organization thymoma subtypes and thymic carcinomaFrederick Pfister, Hussam Hussain, Djeda Belharazem, et al.
Oncotarget|December 15, 2016
LEF1 reduces tumor progression and induces myodifferentiation in a subset of rhabdomyosarcomaJulia Dräger, Katja Simon-Keller, Tobias Pukrop, et al.
Scientific Reports|September 28, 2016
Gene expression profiling reveals aryl hydrocarbon receptor as a possible target for photobiomodulation when using blue lightAnja Becker, Anna Klapczynski, Natalia Kuch, et al.
Frontiers in Pediatrics|December 21, 2018
Canonical WNT/β-Catenin Signaling Plays a Subordinate Role in RhabdomyosarcomasNada Ragab, Florian Viehweger, Julia Bauer, et al.
Pageof 3